Page last updated: 2024-09-05

l 778,123 and Emesis

l 778,123 has been researched along with Emesis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bernhard, EJ; DeLaney, TF; Deutsch, P; Hahn, SM; Haller, DG; Kiel, KD; McKenna, WG; Mohiuddin, M; Morrison, B; Muschel, RJ; Pramanik, B; Regine, W; Smith, D; Stevenson, JP; Tepper, J	1

Trials

1 trial(s) available for l 778,123 and Emesis

Article	Year
A Phase I trial of the farnesyltransferase inhibitor L-778,123 and radiotherapy for locally advanced lung and head and neck cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:5 Topics: Adult; Aged; Alkyl and Aryl Transferases; Carcinoma, Non-Small-Cell Lung; Cell Survival; Combined Modality Therapy; Dose-Response Relationship, Radiation; Farnesyltranstransferase; Female; Head and Neck Neoplasms; Hematologic Diseases; Humans; Imidazoles; Lung Neoplasms; Male; Middle Aged; Mouth Mucosa; Nausea; Skin Diseases; Stomatitis; Treatment Outcome; Tumor Cells, Cultured; Vomiting	2002

Article

Year

A Phase I trial of the farnesyltransferase inhibitor L-778,123 and radiotherapy for locally advanced lung and head and neck cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:5

Topics: Adult; Aged; Alkyl and Aryl Transferases; Carcinoma, Non-Small-Cell Lung; Cell Survival; Combined Modality Therapy; Dose-Response Relationship, Radiation; Farnesyltranstransferase; Female; Head and Neck Neoplasms; Hematologic Diseases; Humans; Imidazoles; Lung Neoplasms; Male; Middle Aged; Mouth Mucosa; Nausea; Skin Diseases; Stomatitis; Treatment Outcome; Tumor Cells, Cultured; Vomiting

2002